Pharmafile Logo

TVF Communications

- PMLiVE

Amgen gets prevention claim for cholesterol drug Repatha

FDA approves new labelling on heart attack and stroke risk reduction

- PMLiVE

Akili to submit video game ADHD treatment for US approval in 2018

Follows trial suggesting attention benefits of its 'digital medicine' AKL-T01

- PMLiVE

Mylan gets first biosimilar Herceptin OK from FDA

Ogivri approved by US regulators for all of Roche blockbuster's indications

Digital transformation: What it means and how to get started

Digital transformation is one of those things that everyone seems to be talking about, yet no one really knows how to do it – or even what it is. So...

Anthill Agency

- PMLiVE

Immodulon Therapeutics bolsters senior team

Dr Jerome Zeldis and Dr Graham Burton join as executive vice chairman and COO

Pfizer names Albert Bourla as COO

John Young and Angela Hwang also take up new positions at the pharma firm

Patient centricity: Reality or rhetoric?

Everybody is talking about patient centricity, but what does it mean for those involved in market research, insights and business intelligence?

Inizio

Review of Disease Promotion Campaign using Facial Analysis

Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign...

Inizio

Emotional Recognition using Facial Analysis

Do you have a poker face or does your expression give you away?  According to psychologists, a lot of emotional information can be drawn from our facial expressions, which is...

Inizio

Living with NASH: An Unexpected Diagnosis

Published in eyeforpharma November 2017 by Mariel Metcalfe

Inizio

- PMLiVE

Roche offers diabetes digital health programme to UK patients

Partners with OurPath for its six-week lifestyle management programme

- PMLiVE

FDA approves first Apple Watch medical device accessory

Kardia Band functions as a real-time electrocardiogram

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links